NetworkNewsAudio

FridayMar 29, 2019 8:00 am

NetworkNewsAudio – Genprex Inc. (NASDAQ: GNPX) Establishing Itself as a Trailblazer in Breakthrough Cancer Treatments

Related Editorial Pharmaceutical companies are now employing advanced medical breakthroughs and new technologies, including gene therapies and nanoparticle engineering, to fight every type of cancer. Gene therapies are being developed to more effectively target the treatment of cancer. Non-small cell lung cancer (NCSLC) is the leading cause of cancer death. Genprex Inc. is advancing Oncoprex, shown to benefit lung cancer patients in early trials. A multiplicity of potential breakthrough treatments to fight cancer are in varying stages of clinical development, and many are focused on the promise of advanced gene therapies. Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) is working to bring…

Continue Reading

FridayMar 22, 2019 8:00 am

NetworkNewsAudio – Net Element, Inc. (NASDAQ: NETE) Capitalizes on Growing Market with Integrated Payment Solution

Related Editorial Payment processing companies are seeing impressive growth and may present attractive investment options by providing diverse services. Changing technology and spending habits are forcing payment systems to change. New providers are emerging to challenge banks and old providers. By providing diverse services, these providers cater to a range of specific markets. Adaptable technology helps to future proof these innovations. Net Element (NASDAQ: NETE) (NETE Profile) is capitalizing on this growing space by providing an integrated payment solution that includes online, mobile and smart point-of-sale payments solutions for merchants in diverse industries. Square Inc. (NYSE: SQ) is working with…

Continue Reading

MondayMar 18, 2019 8:45 pm

NetworkNewsAudio – Genprex Inc. (NASDAQ: GNPX) Interview

About Genprex, Inc. Genprex (NASDAQ: GNPX) is a clinical stage gene therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex(TM) immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and…

Continue Reading

ThursdayMar 14, 2019 8:00 am

NetworkNewsAudio – Genprex Inc. (NASDAQ: GNPX) Developing Treatments to Fight Lung Cancer

Related Editorial After thirty years of development, gene therapy is seeing a surge of progress and profitability. Gene therapies tackle diseases by altering the genetic makeup of patients’ cells. Recent mergers and research developments make this a promising time to invest in the sector. Gene therapy companies are developing treatments for everything from cancer and HIV to skin diseases. Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) is developing treatments to tackle lung cancer. Spark Therapeutics Inc. (NASDAQ: ONCE), which recently entered a merger agreement with the Roche Group, targets ailments such as retinal and neurodegenerative diseases. Dyadic International Inc. (OTCQX: DYAI)…

Continue Reading

FridayMar 08, 2019 8:00 am

NetworkNewsAudio – Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Reports Positive Cyclops Project Results as Interest in Electric Vehicles Gains Momentum

Related Editorial The need for nickel for batteries is driving greater investment in mines in Indonesia. Batteries play vital role in modern society, powering everything from phones to EVs. Pacific Rim Cobalt Corp. releases assay results confirming strong nickel, cobalt mineralization in Cyclops Project. As the world’s leading source of nickel, Indonesia is seeing serious investments. Pacific Rim Cobalt Corporation (OTCQB: PCRCF) (CSE: BOLT) (PCRCF Profile) just announced assay results from its ongoing 2019 drilling campaign at the Cyclops, Nickel/Cobalt Project in Indonesia. VALE S.A. (NYSE: VALE) has also invested heavily in Indonesian nickel production. Glencore (OTC: GLNCY) both mines…

Continue Reading

ThursdayMar 07, 2019 8:30 am

NetworkNewsAudio – BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) Interview

About BriaCell BriaCell is an immuno-oncology focused biotechnology company developing a targeted and safe approach to the management of cancer. Immunotherapy has come to the forefront in the fight against cancer, harnessing the body’s own immune system in recognizing and selectively destroying cancer cells while sparing normal ones. Immunotherapy, in addition to generally being more targeted and less toxic than commonly used types of chemotherapy, is also thought to be a potent approach with the potential to prevent cancer recurrence. For more information, visit the company’s website at www.BriaCell.com About NetworkNewsAudio NetworkNewsAudio, a service of NetworkNewsWire (NNW), allows you to…

Continue Reading

TuesdayMar 05, 2019 8:00 am

NetworkNewsAudio – SinglePoint, Inc. (SING) Seizes Opportunity in the Solar Energy Industry

Related Editorial With climate change a hot topic and the Green New Deal providing a possible pathway for progress, solar power may be a more viable — and profitable — source of energy than ever before. Significant growth, ample resources point toward bright solar energy future SinglePoint acquisition provides phenomenal opportunity for company to establish industry foothold Experts predict solar could be main power source of choice in the coming Recognizing a building interest in and support of renewable energy sources such as solar energy, smart companies are finding ways to establish a strong foothold in the sector. SinglePoint Inc.…

Continue Reading

ThursdayFeb 28, 2019 8:00 am

NetworkNewsAudio – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Interview

About the Green Organic Dutchman Holdings Ltd.  The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) is a publicly traded, premium global organic cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The company grows high-quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned global capacity of 219,000 kgs. and is building 1,643,600 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark.…

Continue Reading

WednesdayFeb 13, 2019 8:00 am

NetworkNewsAudio – Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) Interview

About Black Iron Inc. Black Iron (TSX: BKI) (OTC: BKIRF) (GR: BIN) is an iron ore exploration and development company, advancing its 100 percent owned Shymanivske project located in Kryviy Rih, Ukraine. The Shymanivske project contains a NI 43-101 compliant resource estimated to be 646 Mt Measured and Indicated mineral resources, consisting of 355 Mt Measured mineral resources grading 31.6 percent total iron and 18.8 percent magnetic iron, and Indicated mineral resources of 290 Mt grading 31.1 percent total iron and 17.9 percent magnetic iron, using a cut-off grade of 10 percent magnetic iron. Additionally, the Shymanivske project contains 188…

Continue Reading

TuesdayJan 22, 2019 1:45 pm

NetworkNewsAudio – Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Pursuing an Alternative to Cigarettes Using Proprietary Technology

Related Editorial In a country where the life-threatening risks of smoking are well-known and 22 million smokers want to quit, a milestone agreement between a drug delivery platform innovator and one of the world’s largest producers and marketers of tobacco and cigarettes may offer tobacco users an alternative method of satisfying their needs along with greatly reduced risk. The quest for other alternatives to cigarettes has brought Big Tobacco to the door of biotech company Lexaria. The bioscience potential for nicotine delivery cannot be ignored and may deliver myriad benefits. Lexaria’s proprietary DehydraTECH technology makes the company an ideal partner. Lexaria…

Continue Reading